Skip to main content

INSTITUTE OF ANESTHESIOLOGY AND INTENSIVE THERAPY

 

INTRODUCTION 

 

The patient care activities of the Institute of Anesthesiology and Intensive Therapy (AITI) is divided into three 
main areas: anesthesiology, intensive therapy and pain management.
Surgery and examinations performed by doctors and anesthesiologist assistants. The annual 
number of anesthesia cases exceeds 30,000. In order to reduce the fear and perioperative risk 
of patients, we consider it important to thoroughly examine each patient before surgery and, 
if necessary, to propose treatment changes. We practise all anaesthesia fields except cardiac 
surgery anesthesia.
Our nurses work in the world-class equipped, 16-bed central intensive care unit, and also provide 
their services for the 9-bed intensive care unit of the Neurosurgery Clinic. In the two departments, 
we treat more than 1,600 patients every year. Our central intensive care unit is ready to receive 
life-threatening patients from any hospital department.
In our institute, we already have electronic documentation in anesthesia. We perform a large number of 
Continuous Renal Replacement Therapy (CRRT), and we are able to carry out Extracorporeal Membrane 
Oxygenation (ECMO) treatment, too.
The pain management clinic has been receiving the patients who suffer from persistent, unbearable pain. Annually we 
treat 850 patients with medication and equipment. The leader of our department is a European pain management 
specialist.
Our clinical trials were performed primarily in the field of diagnosis and therapy of sepsis, and in the field of mechanical 
ventilation.


Number of clinical trial investigators with Good Clinical Practice (GCP) certificate :
Number of clinical trial doctors with Good Clinical Practice (GCP) certificate: 1
Number of specialist doctors with Clinical Pharmacology certificate: 0

 

 

EQUIPMENT FOR CLINICAL TRIALS 

- special ultrasound devices (2)
- electronic patient data management system in intensive care
- uniform, high level of development? ventilators (16 pcs.)
- elastometric hemostasis device

 

 

REFERENCE CLINICAL TRIALS

 

 

 

Protocol Identifier 

Name of Study 

Principal Investigator

1

IC43-201

Study Assessing Immunogenicity and Safety of IC43 in Intensive 
Care Patients

Dr. Lajos Bogár

2

IC43-202

A confirmatory phase II/III study assessing efficacy…

Dr. Lajos Bogár

3

ART-123

A randomized, double-blind placebo-controlled phase 3 study…

Dr. Lajos Bogár

 

 

OUR PUBLICATIONS

 

Rello J, Krenn CG, Locker G, Pilger E, Madl C, Balica L, Dugernier T, Laterre PF, Spapen H, Depuydt P, Vincent JL, Bogár L, Szabó Z, Völgyes B, Máñez R, Cakar N, Ramazanoglu A, Topeli A, Mastruzzo MA, Jasovich A, Remolif CG, Del Carmen Soria L, Andresen Hernandez MA, Ruiz Balart C, Krémer I, Molnár Z, von Sonnenburg F, Lyons A, Joannidis M, Burgmann H, Welte T, Klingler A, Hochreiter R, Westritschnig K. A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients. Critical Care. 2017 Feb 4;21(1):22. doi: 10.1186/s13054-017-1601-9.

 

Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF; EUROBACT Investigators. Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey. Critical Care. 2013 Dec 10;17(6):R289. doi: 10.1186/cc13153.

 

Breen D, Bogar L, Heigl P, Rittberger J, Shorten GD. Validation of a clinical assessment tool for spinal anaesthesia. Acta Anaesthesiology Scandinavica. 2011 Jul;55(6):653-7. doi: 10.1111/j.1399-6576.2011.02433.x.

 

Toth K, Bogar L, Juricskay I, Keltai M, Yusuf S, Haywood LJ, Meiselman HJ. The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction. Clinical Hemorheology and Microcirculation. 1997 Mar-Apr;17(2):117-25.

 

Walker RT, Matrai A, Bogar L, Dormandy JA. Serotonin and the flow properties of blood. Journal os Cardiovascular Pharmacology. 1985;7 Suppl 7:S35-7.

 

Gondos T, Marjanek Z, Ulakcsai Z, Szabó Z, Bogár L, Károlyi M, Gartner B, Kiss K, Havas A, Futó J. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. European Journal of Anaesthesiology. 2010 Sep;27(9):794-800. doi: 10.1097/EJA.0b013e32833b3504.

 

  

PRINCIPAL INVESTIGATORS

 

 

Dr. Lajos Bogár

Bogár Lajos

 

SCIENTIFIC DEGREE 

D.Sc.

POSITION 

University Professor

QUALIFICATIONS 

Anesthesiology and Intensive Care

SCIENTIFIC INTEREST 

Anesthesiology, Intensive Therapy 

REFERENCE CLINICAL TRIALS 

IC43-201, number of patients included: 11
IC43-202, number of patients included: 5
ART-123, number of patients enrolled: 0
AVAILABLE FOR PERFORMING 
CLINICAL TRIALS

Phase 3-4

 

 

Dr. Krisztián Jáksó

 

SCIENTIFIC DEGREE 

n.a.

POSITION 

Chief Clinical Physician

QUALIFICATIONS 

Anesthesiology and Intensive Care

SCIENTIFIC INTEREST 

Intensive Therapy

REFERENCIA VIZSGÁLATOK

IC43-201, bevont betegek száma: 11

IC43-202, bevont betegek száma: 5

ART-123, bevont betegek száma: 0

AVAILABLE FOR PERFORMING
CLINICAL TRIALS 

Phase 3-4

  

 

 

 

 

 

STUDY TEAM

 

The clinic currently does not have its own coordinator and study nurse. You need to contact
the Coordination Centre for Clinical Trials (KVKK).

 

References
[1] https://www.ncbi.nlm.nih.gov/pubmed/28159015  [2] https://www.ncbi.nlm.nih.gov/pubmed/24326145  [3] 
https://www.ncbi .nlm.nih.gov/pubmed/9255435 [4] https://www.ncbi.nlm.nih.gov/pubmed/2412054  [5]
https://www.ncbi.nlm.nih.gov/pubmed/20520555 

 

 

Létrehozva: 2019.08.21.

Utoljára frissítve: 2019.09.04.